Business

US Medicare sets cracking unit price for Proteomics diabetes test

Proteomics has scored a major US win, with Medicare setting a US$390.75 reimbursement price for its predictive kidney disease blood test, clearing the path for nationwide clinical uptake.

Business / Companies

Brisbane Times – Business

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Business